You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康希諾(688185.SH):上藥康希諾擬向上海醫藥方面借調部分人員為其提供技術諮詢、綜合管理等服務

格隆匯7月16日丨康希諾(688185.SH)公佈,公司子公司上海上藥康希諾生物製藥有限公司(上藥康希諾)擬向上海醫藥集團股份有限公司(上海醫藥)及其下屬公司借調部分人員為上藥康希諾提供技術諮詢、綜合管理等服務

上藥康希諾擬就上述事項與上海醫藥簽訂《人員借調服務框架協議》,借調期限自協議簽訂之日起2022531日,預計前述《人員借調服務框架協議》項下交易發生額預計不超過6000萬元人民幣。

截至公吿披露日,公司持有上藥康希諾49.80%的股份,上海三維生物技術有限公司(上藥三維生物)持有其49.00%的股份上海生物醫藥產業股權投資基金合夥企業(有限合夥)(產業投資基金)持有其1.20%股份公司與產業投資基金已簽署一致行動協議,上藥康希諾為公司控制的子

持有上藥康希諾49%股份的股東上藥三維生物為上海醫藥控制的公司據《上海證券交易所科創板股票上市規則》《香港聯合交易所有限公司證券上市規則》的相關規定,公司根據謹慎性原則,將本次交易比照關聯交易履行審議程序和披露

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account